Search Results

Influenza vaccine (intranasal, live attenuated) (LAIV trivalent): Influenza Virus Type A H1N1, Influenza Virus Type A H3N2, Influenza Virus Type B (Victoria lineage) 107±0.5 FFU Influenza Virus Type B (Victoria lineage) New SFDA Drug Approvals

An Open-label Extension Study to Evaluate Long-term Efficacy and Safety of A4250 in Children with Progressive Familial Intrahepatic Cholestasis Types 1 and 2 (PEDFIC 2) Drug Clinical Trial

An Open-label Extension Study to Evaluate Long-term Efficacy and Safety of A4250 in Children with Progressive Familial Intrahepatic Cholestasis Types 1 and 2 (PEDFIC 2) Drug Clinical Trial

Outcomes of Extended Depth of Focus IOL versus Monofocal IOL Implantation After Phacoemulsification in Glaucoma Patients Clinical Trial

Safety and clinical performance of the Yukon choice PC eluting bioabsorbable polymer stents systems in routine clinical practice Clinical Trial

Safety and clinical performance of the Yukon choice PC eluting bioabsorbable polymer stents systems in routine clinical practice Clinical Trial

A randomized, double blind, placebo controlled, parallel group, pilot study of 1:1 and 20:1 ratio of formulated GWP42003: GWP42004 plus GWP42003 and GWP42004 alone in the treatment of dyslipedemia in subjects with Type 2 diabetes. Drug Clinical Trial

Displaying 591 - 597 of 597